12 research outputs found
Assessing the risk of bias in randomized controlled trials in the field of dentistry indexed in the Lilacs (Literatura Latino-Americana e do Caribe em CiĂȘncias da SaĂșde) database
Isolating shape from semantics in haptic-visual priming
The exploration of a familiar object by hand can benefit its identification by eye. What is unclear is how much this multisensory cross-talk reflects shared shape representations versus generic semantic associations. Here, we compare several simultaneous priming conditions to isolate the potential contributions of shape and semantics in haptic-to-visual priming. Participants explored a familiar object manually (haptic prime) while trying to name a visual object that was gradually revealed in increments of spatial resolution. Shape priming was isolated in a comparison of identity priming (shared semantic category and shape) with category priming (same category, but different shapes). Semantic priming was indexed by the comparisons of category priming with unrelated haptic primes. The results showed that both factors mediated priming, but that their relative weights depended on the reliability of the visual information. Semantic priming dominated in Experiment 1, when participants were free to use high-resolution visual information, but shape priming played a stronger role in Experiment 2, when participants were forced to respond with less reliable visual information. These results support the structural description hypothesis of haptic-visual priming (Reales and Ballesteros in J Exp Psychol Learn Mem Cogn 25:644â663, 1999) and are also consistent with the optimal integration theory (Ernst and Banks in Nature 415:429â433, 2002), which proposes a close coupling between the reliability of sensory signals and their weight in decision making.This work was supported by a PhD scholarship to author AP from the Portuguese Fundação para a CiĂȘncia e Tecnologia (SFRH/BD/76087/2011), an Exchange Fellowship to author AAB from the Dr. Michael Quinn Memorial Fund, Department of Psychology, University of British Columbia, an NSERC (Canada) Discovery Grant to author JTE, and Grants to author SS-F from the Spanish Ministry of Science and Innovation (PSI2010-15426 and Consolider INGENIO CSD2007-00012 Grants, the Comissionat per a Universitats i Recerca del DIUE-Generalitat de Catalunya (SRG2009- 092), and the European Research Council (StG-2010 263145)
Isolated atrial fibrillation (IAF) after local anaesthesia with epinephrine in an anxious dental patient.
Cardiac arrhythmias are not uncommon in dental practice, depending on many factors, including patient features, dental
treatment and drugs administered. We describe a case of isolated atrial fi brillation (IAF) developed, in a young patient,
soon after a supraperiosteal injection. The patient was admitted to hospital and recovered spontaneously. Since stress is a
possible cause of IAF, this may has been triggered by endogenous and/or exogenous epinephrine. We highlight the need for
careful preoperative evaluation, including anxiety assessment and treatment in all dental patients
Effect of Simvastatin on induced apical periodontitis in rats: a tomographic and biochemical analysis
Isolated atrial fibrillation (IAF) after local anaesthesia with epinephrine in an anxious dental patient
Soluble Guanylate Cyclase Stimulators and Activators.
When Furchgott, Murad, and Ignarro were honored with the Nobel prize for the identification of nitric oxide (NO) in 1998, the therapeutic implications of this discovery could not be fully anticipated. This was due to the fact that available therapeutics like NO donors did not allow a constant and long-lasting cyclic guanylyl monophosphate (cGMP) stimulation and had a narrow therapeutic window. Now, 20Â years later, the stimulator of soluble guanylate cyclase (sGC), riociguat, is on the market and is the only drug approved for the treatment of two forms of pulmonary hypertension (PAH/CTEPH), and a variety of other sGC stimulators and sGC activators are in preclinical and clinical development for additional indications. The discovery of sGC stimulators and sGC activators is a milestone in the field of NO/sGC/cGMP pharmacology. The sGC stimulators and sGC activators bind directly to reduced, heme-containing and oxidized, heme-free sGC, respectively, which results in an increase in cGMP production. The action of sGC stimulators at the heme-containing enzyme is independent of NO but is enhanced in the presence of NO whereas the sGC activators interact with the heme-free form of sGC. These highly innovative pharmacological principles of sGC stimulation and activation seem to have a very broad therapeutic potential. Therefore, in both academia and industry, intensive research and development efforts have been undertaken to fully exploit the therapeutic benefit of these new compound classes. Here we summarize the discovery of sGC stimulators and sGC activators and the current developments in both compound classes, including the mode of action, the chemical structures, and the genesis of the terminology and nomenclature. In addition, preclinical studies exploring multiple aspects of their in vitro, ex vivo, and in vivo pharmacology are reviewed, providing an overview of multiple potential applications. Finally, the clinical developments, investigating the treatment potential of these compounds in various diseases like heart failure, diabetic kidney disease, fibrotic diseases, and hypertension, are reported. In summary, sGC stimulators and sGC activators have a unique mode of action with a broad treatment potential in cardiovascular diseases and beyond
Outcomes from elective colorectal cancer surgery during the SARSâCoVâ2 pandemic
Aim
This study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic.
Method
This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS-CoV-2. Centres entered data from their first recorded case of COVID-19 until 19 April 2020. The primary outcome was 30-day mortality. Secondary outcomes included anastomotic leak, postoperative SARS-CoV-2 and a comparison with prepandemic European Society of Coloproctology cohort data.
Results
From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty-day mortality was 1.8% (38/2073), the incidence of postoperative SARS-CoV-2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS-CoV-2 (14/1601, 0.9%) and highest in patients with both a leak and SARS-CoV-2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58â14.06), postoperative SARS-CoV-2 (16.90, 7.86â36.38), male sex (2.46, 1.01â5.93), age >70 years (2.87, 1.32â6.20) and advanced cancer stage (3.43, 1.16â10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).
Conclusion
Surgeons need to further mitigate against both SARS-CoV-2 and anastomotic leak when offering surgery during current and future COVID-19 waves based on patient, operative and organizational risks
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study
AimThe SARS-CoV-2 pandemic has provided a unique opportunity to explore the impact of surgical delays on cancer resectability. This study aimed to compare resectability for colorectal cancer patients undergoing delayed versus non-delayed surgery.MethodsThis was an international prospective cohort study of consecutive colorectal cancer patients with a decision for curative surgery (January-April 2020). Surgical delay was defined as an operation taking place more than 4âweeks after treatment decision, in a patient who did not receive neoadjuvant therapy. A subgroup analysis explored the effects of delay in elective patients only. The impact of longer delays was explored in a sensitivity analysis. The primary outcome was complete resection, defined as curative resection with an R0 margin.ResultsOverall, 5453 patients from 304 hospitals in 47 countries were included, of whom 6.6% (358/5453) did not receive their planned operation. Of the 4304 operated patients without neoadjuvant therapy, 40.5% (1744/4304) were delayed beyond 4âweeks. Delayed patients were more likely to be older, men, more comorbid, have higher body mass index and have rectal cancer and early stage disease. Delayed patients had higher unadjusted rates of complete resection (93.7% vs. 91.9%, PÂ =Â 0.032) and lower rates of emergency surgery (4.5% vs. 22.5%, PâConclusionOne in 15 colorectal cancer patients did not receive their planned operation during the first wave of COVID-19. Surgical delay did not appear to compromise resectability, raising the hypothesis that any reduction in long-term survival attributable to delays is likely to be due to micro-metastatic disease